CN111346081A - 包含正戊酸、吲哚丙酸和正丁酸钠的药物组合物的新用途 - Google Patents
包含正戊酸、吲哚丙酸和正丁酸钠的药物组合物的新用途 Download PDFInfo
- Publication number
- CN111346081A CN111346081A CN202010172134.7A CN202010172134A CN111346081A CN 111346081 A CN111346081 A CN 111346081A CN 202010172134 A CN202010172134 A CN 202010172134A CN 111346081 A CN111346081 A CN 111346081A
- Authority
- CN
- China
- Prior art keywords
- acid
- sodium
- butyrate
- pharmaceutical composition
- pentanoic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010172134.7A CN111346081B (zh) | 2020-03-12 | 2020-03-12 | 包含正戊酸、吲哚丙酸和正丁酸钠的药物组合物的新用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010172134.7A CN111346081B (zh) | 2020-03-12 | 2020-03-12 | 包含正戊酸、吲哚丙酸和正丁酸钠的药物组合物的新用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111346081A true CN111346081A (zh) | 2020-06-30 |
CN111346081B CN111346081B (zh) | 2021-06-15 |
Family
ID=71189810
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010172134.7A Active CN111346081B (zh) | 2020-03-12 | 2020-03-12 | 包含正戊酸、吲哚丙酸和正丁酸钠的药物组合物的新用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111346081B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113440522A (zh) * | 2021-07-29 | 2021-09-28 | 中山大学附属第七医院(深圳) | 一种吲哚丙酸在制备用于治疗自闭症药物中的应用 |
WO2022034349A1 (en) * | 2020-08-11 | 2022-02-17 | Debreceni Egyetem | Treatment and diagnosis of breast cancer |
CN114259483A (zh) * | 2020-09-16 | 2022-04-01 | 广州中医药大学第一附属医院 | 一种用于治疗肝细胞癌的药物组合物及其应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103800905A (zh) * | 2014-03-14 | 2014-05-21 | 江苏霖峯细胞技术股份有限公司 | 联合应用c-MET抑制剂与丁酸钠治疗癌症的方法 |
CN108125950A (zh) * | 2017-12-28 | 2018-06-08 | 崔明 | 吲哚丙酸在制备用于预防和/或治疗肿瘤放疗副反应的药物中的用途 |
CN108186631A (zh) * | 2017-12-28 | 2018-06-22 | 崔明 | 一种药物组合物及其制备方法和用途 |
-
2020
- 2020-03-12 CN CN202010172134.7A patent/CN111346081B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103800905A (zh) * | 2014-03-14 | 2014-05-21 | 江苏霖峯细胞技术股份有限公司 | 联合应用c-MET抑制剂与丁酸钠治疗癌症的方法 |
CN108125950A (zh) * | 2017-12-28 | 2018-06-08 | 崔明 | 吲哚丙酸在制备用于预防和/或治疗肿瘤放疗副反应的药物中的用途 |
CN108186631A (zh) * | 2017-12-28 | 2018-06-22 | 崔明 | 一种药物组合物及其制备方法和用途 |
Non-Patent Citations (1)
Title |
---|
王英等: "丁酸钠调控HepG2 细胞的增殖、凋亡和侵袭", 《安徽医药》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022034349A1 (en) * | 2020-08-11 | 2022-02-17 | Debreceni Egyetem | Treatment and diagnosis of breast cancer |
CN114259483A (zh) * | 2020-09-16 | 2022-04-01 | 广州中医药大学第一附属医院 | 一种用于治疗肝细胞癌的药物组合物及其应用 |
CN113440522A (zh) * | 2021-07-29 | 2021-09-28 | 中山大学附属第七医院(深圳) | 一种吲哚丙酸在制备用于治疗自闭症药物中的应用 |
Also Published As
Publication number | Publication date |
---|---|
CN111346081B (zh) | 2021-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111346081B (zh) | 包含正戊酸、吲哚丙酸和正丁酸钠的药物组合物的新用途 | |
USRE40862E1 (en) | Gossypolone for the treatment of cancer | |
US11020392B2 (en) | Use of trimetazidine as a hepatoprotective medicine in prevention and treatment of liver diseases and conditions | |
US20160000793A1 (en) | Sodium channel blocker for treatment of loss of superficial sensitivity | |
JP2015229675A (ja) | 膵臓癌を治療するための医薬製剤 | |
WO2021196659A1 (zh) | 糖基聚醚类化合物脂质体及其制备方法和药物 | |
BG65847B1 (bg) | Приложение на производни на бигуанидина за получаване на лекарствено средство с цикатризиращ ефект | |
CN113925867A (zh) | 盐酸决奈达隆联合5-氟尿嘧啶在制备抗肿瘤药物中的应用 | |
CN101361732B (zh) | 一种含有藤黄酸的药物制剂及其用途 | |
RU2760324C1 (ru) | Новое применение полоксамера в качестве фармакологически активного вещества | |
CN111450089A (zh) | Bepridil或KB-R7943在制备治疗黑色素瘤的药物中的应用 | |
GB2039736A (en) | Pharmaceutical compositions containing thiazolidine-4-carboxylic acid and method of preparation | |
Gangadharam et al. | Chemotherapy of tuberculosis in mice using single implants of isoniazid and pyrazinamide | |
CN104902901A (zh) | 使用cbp/连环蛋白的抑制剂治疗过度增殖性和癌前皮肤病 | |
RU2282438C1 (ru) | Средство, обладающее противоопухолевой активностью | |
CN103284982A (zh) | 用于治疗癌症转移的方法和组合物 | |
Cusini et al. | Primary cutaneous cryptococcosis in a patient with the acquired immunodeficiency syndrome | |
JP3696297B2 (ja) | 肝再生用治療剤 | |
CN107320471B (zh) | 一种治疗结核病的环丝氨酸药物组合物及其应用 | |
CA2353613A1 (en) | Preparations for intraurethral administration | |
RU2523792C1 (ru) | Лекарственное средство для лечения туберкулеза | |
CN109498547A (zh) | 一种平阳霉素局部注射制剂及其制备方法 | |
RU2676279C1 (ru) | Стабильное противоопухолевое лекарственное средство, способ его получения и применения | |
US11617729B2 (en) | Uses of guanidine hydrochloride as a drug for treating cancers/tumors | |
CN109381466A (zh) | 促进糖尿病病人伤口愈合的治疗剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: No. 238, Baidi Road, Nankai District, Tianjin Applicant after: Cui Ming Applicant after: Zhang Shuqin Applicant after: Xiao Huiwen Applicant after: Li Yuan Applicant after: Dong Jiali Address before: No. 238, Baidi Road, Nankai District, Tianjin Applicant before: Cui Ming Applicant before: Zhang Shuqin Applicant before: Xiao Huiwen Applicant before: Li Yuan Applicant before: Dong Jiali |
|
CB02 | Change of applicant information | ||
CB03 | Change of inventor or designer information |
Inventor after: Cui Ming Inventor after: Zhang Shuqin Inventor after: Xiao Huiwen Inventor after: Li Yuan Inventor after: Dong Jiali Inventor before: Cui Ming Inventor before: Zhang Shuqin Inventor before: Xiao Huiwen Inventor before: Li Yuan Inventor before: Dong Jiali |
|
CB03 | Change of inventor or designer information | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230710 Address after: 300192, 238 Bai Causeway Road, Tianjin, Nankai District Patentee after: INST OF RADIATION MEDICINE CHINESE ACAD OF MEDICAL SCIENCES Address before: No. 238, Baidi Road, Nankai District, Tianjin 300292 Patentee before: Cui Ming Patentee before: Zhang Shuqin Patentee before: Xiao Huiwen Patentee before: Li Yuan Patentee before: Dong Jiali |
|
TR01 | Transfer of patent right |